









Markets
/
Stocks
/
nasdaq-iobt
/

IO Biotech Inc

IOBT

View Detailed Chart

2.220USD

-0.010-0.45%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

146.26MMarket Cap

LossP/E TTM



IO Biotech Inc

2.220

-0.010-0.45%

Overview Company Financials

Financials

Intraday

30m

Today

-0.45%

5 Days

+7.77%

1 Month

+48.99%

6 Months

+149.44%

Year to Date

+141.30%

1 Year

+81.97%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 6 analysts

BUY

Current Rating

9.500

Target Price

327.93%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

IO Biotech Inc

IOBT

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(1)

Neutral(3)

Buy(8)

Indicators

Sell(0)

Neutral(3)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.042

Buy

RSI(14)

66.718

Neutral

STOCH(KDJ)(9,3,3)

57.613

Neutral

ATR(14)

0.227

High Vlolatility

CCI(14)

71.540

Neutral

Williams %R

31.101

Buy

TRIX(12,20)

1.922

Buy

StochRSI(14)

14.709

Oversold

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

2.232

Sell

MA10

2.105

Buy

MA20

1.879

Buy

MA50

1.585

Buy

MA100

1.279

Buy

MA200

1.118

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.

Ticker SymbolIOBT

CompanyIO Biotech Inc

CEODr. Mai-Britt Zocca, Ph.D.

Websitehttps://www.iobiotech.com/